shift toward making multiple medications under one roof is sparking concern about what happens when a facility suddenly shuts down because of a manufacturing or safety issue: Closing a single factory could lead to shortages of hundreds of drugs, say regulators and industry analysts.

Their anxiety is complicated by the tight secrecy surrounding where pharmaceuticals are made, so even experts aren’t certain where or how a supply problem has occurred.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Reminds me of the good old days, when some of the manufacturers would have all their anti-infectives on an island south of Florida, that had to deal with hurricaines ever year and the plant would get damaged and then we had to deal with how to treat patients because of shortages (not FDA/483, etc. related). I just came out of industry and would discuss API (Active Pharmaceutical Ingredient) with our commercial folks who negotiated the API and how a couple companies controlled most of the anti-infectives needed to make drugs, etc. through out the world. When I was in hospital practice when it came to generic drugs, I always wanted to know where the API came from and I would purchase that product, because it was more important to treat patients, than save a few bucks. In the long run, it could actually cost more by having to switch to a different class of drug or another generic.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy